Clinical trials
Lung clinical trials
Below are recruiting lung clinical trials, each written for real people, not researchers. We’re tracking 2,906 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06484816RecruitingPhase 1
TGRX-1942 study for advanced solid tumor or blood cancer
This trial tests an experimental drug (TGRX-1942) for people with advanced solid tumors or blood cancers that have stopped responding to standard treatments. The main goal is to find a safe dose and see how well the drug works.
Hangzhou, ZhejiangAges 18 years+ - NCT06485544RecruitingPhase 2
Immunotherapy before surgery for small cell lung cancer
This trial tests adding a drug called adebrelimab (a type of immunotherapy) before surgery for people with early-stage small cell lung cancer that can be removed. The goal is to see if it helps shrink the tumor and improve outcomes.
Xi'an, ShannxiAges 18–75 - NCT06532149Recruiting
Sexual health and erectile function in men with lung cancer
This study looks at how lung cancer and its treatments affect men's sexual health, including erectile function and hormone levels. If you are a man with advanced lung cancer and are sexually active, researchers want to learn about your experiences and test results.
RomeAges 18–75 - NCT06542107Recruiting
Weaning from a breathing machine after brain injury
This study looks at the best way to help people with a recent brain injury come off a breathing machine (ventilator). It aims to improve the weaning process and reduce time on the ventilator.
Nanjing, JiangsuAges 18 years+ - NCT06572280Recruiting
Non-invasive nerve stimulation for ARDS patients
This trial tests a non-invasive device that stimulates the phrenic nerve (the nerve that controls your diaphragm) to help you breathe on your own sooner. It is for adults with ARDS who have been on a breathing machine for less than two days.
Nanjing, JiangsuAges Any age - NCT07578571RecruitingPhase 1
Testing a New Cancer Treatment Called IM-1617
This is an early-stage study testing a new drug (IM-1617) for advanced solid cancers that have not responded to standard treatments. The drug combines an antibody with a cancer-killing agent and may help people whose cancer has progressed despite prior therapy.
Sarasota, FloridaAges 18 years+ - NCT07309783Recruiting
Lung imaging to guide breathing support in ARDS
This trial uses a special lung imaging technique (EIT) to guide ventilator settings for people with ARDS. It may help improve breathing support and reduce lung injury.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06895148Recruiting
Better breathing with lung-protective ventilation
This trial tests a way to deliver lung-protective ventilation (a method that uses low air volumes to avoid lung injury) to adults on breathing machines. It aims to see if this approach leads to better outcomes.
Minneapolis, MinnesotaAges 18 years+ - NCT03192267Recruiting
Study of lung changes in early rheumatoid arthritis
This study looks at lung health in people with early rheumatoid arthritis (RA). It may help doctors understand how RA affects the lungs soon after diagnosis and guide better care.
Omaha, NebraskaAges 19–90 - NCT06486259Recruiting
Assessing lung injury risk in ventilated patients
This study looks at the risk of lung injury in patients on a ventilator who have ARDS (a severe lung inflammation). It aims to better understand how the lungs respond and to find safer breathing settings for you.
San Juan Bautista, Buenos AiresAges 18–75 - NCT06488118Recruiting
Lung response to inhaled immune stimulant in healthy and asthma
This study tests how the lungs react to breathing in a weak immune-stimulating drug (R848). It includes healthy volunteers and people with mild to moderate asthma to see differences in airway responses.
Cambridge, CambridgeshireAges 18–60 - NCT06490744Recruiting
Lung function after COVID-19 in lung transplant patients
This study looks at how lung function changed over time in lung transplant patients who had a moderate to severe COVID-19 infection. It may help doctors understand how to better care for transplant patients after a serious COVID-19 illness.
StrasbourgAges 18 years+ - NCT06494254Recruiting
Predicting lung function after lung cancer surgery
This study looks at how well your lungs work after surgery for lung cancer. It uses special scans and breathing tests to help doctors better predict your recovery.
Saint Leonards, New South WalesAges 18 years+ - NCT06496048RecruitingPhase 3
Testing lurbinectedin for small cell lung cancer that has returned
This trial compares a new drug combination (lurbinectedin with or without irinotecan) against the standard treatment (topotecan) for people whose small cell lung cancer has come back after initial chemotherapy. It aims to see if the new options work better.
Jilin CityAges 18 years+ - NCT06497530RecruitingPhase 2
Lurbinectedin with serplulimab for extensive-stage SCLC maintenance
This trial tests a combination of two drugs, lurbinectedin and serplulimab, as maintenance therapy after initial chemotherapy for people with extensive-stage small cell lung cancer (SCLC) that hasn't spread to the brain. The goal is to see if this approach helps keep the cancer from growing for longer.
Guangzhou, GuangdongAges 18 years+ - NCT06500949Recruiting
Vagus nerve block to reduce cough after lung surgery
This study tests whether blocking a specific nerve in the lung can reduce coughing after having a lung tumor removed through a small camera (VATS surgery). If you're having this surgery and are generally healthy, you may be able to join.
Hangzhou, ZhejiangAges 18–70 - NCT06501599Recruiting
AI system for spotting COVID-19 lung changes on CT scans
This trial tests an artificial intelligence tool that helps doctors identify lung changes caused by viral pneumonia, like COVID-19, on CT scans. It may lead to faster and more accurate diagnosis for patients.
MoscowAges 18 years+ - NCT06503146RecruitingPhase 2
New imaging tracer for detecting various cancers
This trial tests a new imaging agent, [18F]FAPI-74, which might help detect certain cancers more clearly. The scan looks for a protein called fibroblast activation protein (FAP) that is often found in tumors. If you have one of the listed cancers and are about to start treatment, this study could help doctors see where the cancer is and how it responds to therapy.
Bethesda, MarylandAges 18–120 - NCT06508307RecruitingPhase 1
A study of an injected virus for advanced solid tumors
This trial tests a new treatment where a virus (GC001) is injected directly into a tumor. The virus is designed to attack cancer cells and may help people with advanced solid tumors that haven't responded to other treatments.
Zhengzhou, HenanAges 18–75 - NCT06512207Recruiting
Hormone therapy plus immunotherapy for advanced lung cancer
This trial tests a combination of hormone therapy (androgen deprivation) and an immunotherapy drug (anti-PD-1) for men with advanced lung cancer. It aims to see if this combination slows cancer growth better than standard treatments.
Zhengzhou, HenanAges 60 years+ - NCT06518655Recruiting
Can a breath test tell if a lung nodule is cancer?
This trial is testing a simple breath test to see if it can tell whether a lung nodule is cancer or not. If you have a lung nodule that will be removed by surgery, you may be able to help find out if breathing into a device can replace more invasive tests.
Beijing, Beijing MunicipalityAges 18–80 - NCT06521502Recruiting
Studying inflammation in the heart and lungs in the ICU
This study collects blood samples from people in the ICU with sudden heart or lung problems caused by inflammation. The goal is to learn more about these conditions and improve future treatments.
Fresno, CaliforniaAges 18 years+ - NCT06522347Recruiting
A lung infection registry study in Austria
This study creates a registry of patients in Austria who have a lung infection caused by tuberculosis or similar bacteria. By joining, you help researchers learn more about these infections and how to better treat them.
ViennaAges 18 years+ - NCT06523582Recruiting
Genetic study of neuroendocrine tumors in Mexican patients
This study aims to find genetic causes of neuroendocrine tumors in Mexican patients. By understanding your DNA, researchers hope to improve diagnosis and treatment for people with these rare conditions.
Mexico City, Mexico CityAges 18 years+
Hear when a new Lung trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for lung?
- Yes. Clin2 currently lists 2,906 recruiting lung studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a lung trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a lung trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.